Improved early graft survival in patients receiving aprotinin during orthotopic liver transplantation

Transplant Proc. 2001 Feb-Mar;33(1-2):1345-6. doi: 10.1016/s0041-1345(00)02503-3.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aprotinin / therapeutic use*
  • Female
  • Graft Survival / drug effects*
  • Graft Survival / physiology
  • Humans
  • Liver Transplantation / physiology*
  • Male
  • Middle Aged
  • Serine Proteinase Inhibitors / therapeutic use*
  • Time Factors

Substances

  • Serine Proteinase Inhibitors
  • Aprotinin